Vol. 35 No. 2 (2023)
Home
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Anteriores
Current
Diretrizes para autores
Notícias
Register
Login
Change the language. The current language is:
English
Português (Brasil)
Register
Login
Change the language. The current language is:
English
Português (Brasil)
Vol. 35 No. 2 (2023)
Published 3 July 2023
Edição completa
PDF (Português (Brasil))
Editorial
Anselmo Gomes de Oliveira, Damaris Silveira
107-108
Animal nutrition: an underexplored area of pharmaceutical activity
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp107-108
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp107-108
Review Article
Brenda Conograi, Darla Juliana Kist, Karina Elisa Machado
109-119
Tranexamic acid in the treatment of melasma
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp109-119
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp109-119
Camila Santos Póvoa, Samyra Mara Coelho Caxito, Fabiana Brandão
120-132
MicroBeauty: skin microbiota and the cosmetics association
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp120-132
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp120-132
Roberto De Giorgio
133-147
Caffeine intake almost always affects physical performance and cognitive processes responsible for awareness
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp133-147
PDF
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp133-147
Victor Hugo Schaly Cordova, Paulo Silva Belmonte-de-Abreu
148-190
Psychotropic drugs and COVID-19: therapeutic management
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp148-190
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp148-190
Original article
Larissa Figueiredo Pacheco, Lailla Yasmin Pereira, Gabriel Rodrigues Martins de Freitas, Rênia Glauciene da Silva Sousa, João Marcos de Araujo da Silva, Bruna Carla Cordeiro de Carvalho
191-203
Judicialization of medicines in João Pessoa, PB, Brazil
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp191-203
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp191-203
Patricia Guadalupe Acosta Recalde, Gladys Mabel Maidana de Larroza, Olga Yolanda Maciel de Segovia, Gladys Beatriz Lugo Rodriguez, Lourdes Raquel Samaniego Silva
204-213
Detection of potentially inappropriate prescriptions according to the STOPP/START criteria in ambulatory patients at a social security hospital
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp204-213
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp204-213
Camila Yumi Ushirobira, Vanessa Nascimento de Andrade Bastos, Larissa Ferreira da Silva, Jessica Amarante de Oliveira
214-222
Budgetary impact analysis of qPCR P210 test incorporation for the follow-up for patients with chronic myeloid leukemia in a tertiary hospital in the Federal District, Brazil
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp214-222
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp214-222
Technical Note
Caroline Pereira Domingueti
223-240
Laboratory Tests and the Pharmaceutical Care for Patients with Diabetes Mellitus: a Literature Review
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp223-240
PDF (Português (Brasil))
DOI:
https://doi.org/10.14450/2318-9312.v35.e2.a2023.pp223-240
×
Username
*
Required
Password
*
Required
Forgot your password?
Keep me logged in
Login
No account?
Register here